A new partnership has just been announced by the University of Chicago Medicine. This partnership with Eric Lefkofsky’s Tempus Technologies is taking aim at cancer in a whole new way. For the past several decades, cancer treatments have been widely a “one shoe fits all” kind of endeavor. Now, scientists and doctors are hoping they can create a new way of treating cancer that will specialize the treatment to just one person’s genetic makeup. Using new technology, molecular sequence and analysis will be done for each patient to determine their optimal cancer treatment method. Scientists are hopeful that this will mean the new cancer treatments will not only be more cost-effective for patients, but that they will be able to eventually find a cure as well.
Eric Lefkofsky is no stranger to partnerships and technologies like this one. In fact, he has created several companies that focus on disruptive technologies and providing new and unusual solutions for their customers. Lefkofsky created Groupon, Lightbank, Uptake Technologies, Mediaocean, and Echo Global Logistics. All of these companies using new technologies to disrupt their markets and create profits for shareholders.Lefkofsky is also a distinguished professor, having tough applied technology and business modeling at DePaul University’s Kellstadt Graduate School of Business and Northwestern University\s Kellogg School of Management. He is currently teaching at the University of Chicago and is the author of Accelerated Disruption.
Whenever Lefkofsky is not working on new technologies, he be found working with his wife on their Foundation, the Lefkofsky Family Foundation. Created in 2006, this foundation focuses on projects and initiatives in the communities surrounding Chicago. They have already helped over 50 organizations meet their goals and start new projects, and they are just getting started.Eric Lefkofsky is definitely a disrupter in the business world. He is focused on creating new technology that will bring new solutions to customers, and he is not stopping his work anytime soon.